Found: 20
Select item for more details and to access through your institution.
Using the CYP3A Activity Evaluation to Predict the Efficacy and Safety of Diazepam in Patients With Alcohol Withdrawal Syndrome.
- Published in:
- Journal of Pharmacy Practice, 2022, v. 35, n. 4, p. 518, doi. 10.1177/0897190021997000
- By:
- Publication type:
- Article
Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2019, v. 12, p. 329, doi. 10.2147/PGPM.S217725
- By:
- Publication type:
- Article
CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2018, v. 11, p. 107, doi. 10.2147/PGPM.S159708
- By:
- Publication type:
- Article
Effects of <em>ABCB1 rs1045642</em> polymorphisms on the efficacy and safety of amlodipine therapy in Caucasian patients with stage I–II hypertension.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2018, v. 11, p. 157, doi. 10.2147/PGPM.S158401
- By:
- Publication type:
- Article
The impact of <em>ABCB1</em> (rs1045642 and rs4148738) and <em>CES1</em> (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2018, v. 11, p. 127, doi. 10.2147/PGPM.S169277
- By:
- Publication type:
- Article
Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2018, v. 11, p. 43, doi. 10.2147/PGPM.S157111
- By:
- Publication type:
- Article
Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 253, doi. 10.2147/PGPM.S141935
- By:
- Publication type:
- Article
Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 243, doi. 10.2147/PGPM.S143250
- By:
- Publication type:
- Article
Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 209, doi. 10.2147/PGPM.S140700
- By:
- Publication type:
- Article
CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 107, doi. 10.2147/PGPM.S126305
- By:
- Publication type:
- Article
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation.
- Published in:
- Pharmacology, 2022, v. 107, n. 3/4, p. 216, doi. 10.1159/000521531
- By:
- Publication type:
- Article
Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis.
- Published in:
- Molecular Biology Reports, 2019, v. 46, n. 3, p. 2761, doi. 10.1007/s11033-019-04722-w
- By:
- Publication type:
- Article
Effect of CYP3A4, CYP3A5, ABCB1 Gene Polymorphisms on Rivaroxaban Pharmacokinetics in Patients Undergoing Total Hip and Knee Replacement Surgery.
- Published in:
- High Blood Pressure & Cardiovascular Prevention, 2019, v. 26, n. 5, p. 413, doi. 10.1007/s40292-019-00342-4
- By:
- Publication type:
- Article
Effect of CYP2C9, PTGS-1 and PTGS-2 gene polymorphisms on the efficiency and safety of postoperative analgesia with ketoprofen.
- Published in:
- Drug Metabolism & Personalized Therapy, 2022, v. 37, n. 4, p. 361, doi. 10.1515/dmpt-2021-0222
- By:
- Publication type:
- Article
Using a pharmacogenetic clinical decision support system to improve psychopharmacotherapy dosing in patients with affective disorders.
- Published in:
- Drug Metabolism & Personalized Therapy, 2020, v. 35, n. 4, p. 1, doi. 10.1515/dmpt-2019-0033
- By:
- Publication type:
- Article
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease.
- Published in:
- Drug Metabolism & Personalized Therapy, 2020, v. 35, n. 1, p. 1, doi. 10.1515/dmpt-2019-0029
- By:
- Publication type:
- Article
How do CYP2C19*2 and CYP2C19*17 genetic polymorphisms affect the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome?
- Published in:
- Drug Metabolism & Personalized Therapy, 2020, v. 35, n. 1, p. 1, doi. 10.1515/dmpt-2019-0026
- By:
- Publication type:
- Article
The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes.
- Published in:
- Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 3, p. 109, doi. 10.1515/dmpt-2018-0006
- By:
- Publication type:
- Article
Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.
- Published in:
- Drug Metabolism & Personalized Therapy, 2017, v. 32, n. 3, p. 129, doi. 10.1515/dmpt-2017-0021
- By:
- Publication type:
- Article
Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome.
- Published in:
- Hospital Pharmacy, 2021, v. 56, n. 5, p. 592, doi. 10.1177/0018578720931756
- By:
- Publication type:
- Article